Nawen Du - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nawen Du

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancers|August 27, 2021

NK Cell Therapy: A Rising Star in Cancer TreatmentNawen Du, Feifei Guo, Yufeng Wang, et al.

Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020

Challenges of evaluating immunotherapy efficacy in solid tumorsRilan Bai, Wenqian Li, Nawen Du, et al.

Frontiers in Oncology|August 28, 2020

Mechanisms of Cancer Resistance to ImmunotherapyRilan Bai, Naifei Chen, Lingyu Li, et al.

Cellular and Molecular Life Sciences : CMLS|July 24, 2024

CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5AFeifei Guo, Nawen Du, Xue Wen, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancers|August 27, 2021

NK Cell Therapy: A Rising Star in Cancer TreatmentNawen Du, Feifei Guo, Yufeng Wang, et al.

Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020

Challenges of evaluating immunotherapy efficacy in solid tumorsRilan Bai, Wenqian Li, Nawen Du, et al.

Frontiers in Oncology|August 28, 2020

Mechanisms of Cancer Resistance to ImmunotherapyRilan Bai, Naifei Chen, Lingyu Li, et al.

Cellular and Molecular Life Sciences : CMLS|July 24, 2024

CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5AFeifei Guo, Nawen Du, Xue Wen, et al.

Pageof 1